Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis

Australian and New Zealand Journal of Psychiatry

Volumn 39, Issue 6, 2005, Pages 487-492

  Wegener, Signy ^a   Redoblado Hodge, Marie Antoinette ^a   Lucas, Sara ^a   Fitzgerald, Dianne ^a   Harris, Anthony ^a,b   Brennan, John ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cognition; Depression; First episode psychosis; Psychopathology; Quality of life

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTENTION; COGNITION; CONTROLLED STUDY; DEPRESSION; ENVIRONMENTAL FACTOR; HUMAN; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MENTAL DISEASE; MULTIPLE REGRESSION; NEGATIVE SYNDROME; NEUROPSYCHOLOGY; POSITIVE SYNDROME; PREDICTION; PSYCHOLOGICAL ASPECT; PSYCHOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SAMPLE SIZE; SCHIZOPHRENIA; SELF REPORT; SOCIAL ASPECT; VARIANCE;

ADULT; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; QUALITY OF LIFE; REGRESSION ANALYSIS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 21744444667     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1614.2005.01608.x     Document Type: Article

References (35)

1. Sartorius N. A WHO method for the assessment of health-related quality of life (WHOQOL). In: Walker S, Rosser R, eds. Quality of life assessment: key issues in the 1990s. Dordrecht: Kluwer Academic, 1990:201-207.
2. Gupta S, Kulhara P, Verma SK. Quality of life in schizophrenia and dysthymia. Acta Psychiatrica Scandinavica 1998; 97:290-296.
3. Katschnig H. Schizophrenia and quality of life. Acta Psychiatrica Scandinavica 2000; 102 (Suppl):33-37.
4. WHOQOL Group. The World Health Organisation WHOQOL-BREF quality of life assessment: position paper from the World Health Organisation. Social Science and Medicine 1998; 46:1569-1585.
5. Dogan S, Dogan O, Tel H, Coker F, Polatoz O, Dogan FB. Psychosocial approaches in outpatients with schizophrenia. Psychiatric Rehabilitation Journal 2004; 27:279-282.
6. Herrman H, Hawthorne G, Thomas R. Quality of life assessment in people living with psychosis. Social Psychiatry and Psychiatric Epidemiology 2002; 37:510-518.
7. Becchi A, Rucci P, Placentino A, Neri G, de Girolamo G. Quality of life in patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology 2004; 39:397-401.
8. Pinikahana J, Happell B, Hope J, Keks NA. Quality of life in schizophrenia: a review of the literature from 1995-2000. International Journal of Mental Health Nursing 2002; 11:103-111.
9. Ho BC, Nopoulos P, Flaum N, Arudt S, Andreasen NC. Two year outcome in first episode schizophrenia: predictive value of symptoms for quality of life. American Journal of Psychiatry 1998; 155:1196-1201.
10. Priebe S, Roeder-Wanner UU, Kaiser W. Quality of life in first-admitted schizophrenia patients: a follow-up study. Psychological Medicine 2000; 30:225-230.
11. Addington J, Addington D. Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin 1999; 25:173-182.
12. Fitzgerald D, Lucas S, Redoblado MA et al. Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics. Australian and New Zealand Journal of Psychiatry 2004; 38:501-510.
13. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophrenia Bulletin 2000; 26:119-136.
14. Meltzer HY, Thompson PA, Lee MA, Ranjan R. Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology 1996; 14 (Suppl):27-33.
15. Buchanan RW, Holstein C, Brier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Society of Biological Psychiatry 1994; 36:717-725.
16. Heslegrave RJ, Awad AG, Voruganti LNP. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. Journal of Psychiatry and Neuroscience 1997; 22:235-242.
17. Aksaray G, Oflu S, Kaptanoglu C, Bal C. Neurocognitive deficits and quality of life in outpatients with schizophrenia. Progress in Neuro-psychopharmacology and Biological Psychiatry 2002; 26:1217-1219.
18. Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophrenia Research 2000; 44:47-56.
19. Harris A, Brennan J, Anderson J et al. The clinical profile of first episode psychosis in Western Sydney - scope and general findings of the Western Sydney First Episode Psychosis Project. Australian and New Zealand Journal of Psychiatry 2005; 39:36-43.
20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn. Washington, DC: American Psychiatric Press, 1994.
21. Lambert T. Switching to risperdal. Melbourne: University of Melbourne, The Multimedia in Psychiatry Unit, 1999.
22. Kay SR, Fizbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987; 13:261-276.
23. Addington J, Addington D. Cognitive functioning in first episode schizophrenia. Journal of Psychiatry and Neuroscience 2002; 27:188-192.
24. Wechsler D. Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: The Psychological Corporation, 1999.
25. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms and commentary. 2nd edn. New York, NY: Oxford University Press, 1998.
26. Conners CK, Multi-health Systems Staff. Conners' Continuous Performance Test. Toronto: MHS, 1995.
27. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Functioning System. San Antonio, TX: The Psychological Corporation, 2001.
28. Hawthorne G, Richardson J, Day N, McNeil H. Validation of the WHOQOL-BREF. Melbourne: Centre for Health Program Evaluation, 2000.
29. Statistical Package for the Social Sciences (SPSS). SPSS for Windows (version 11.0). Chicago: SPSS Inc., 2001.
30. Laroi F, Fannemel M, Ronnebberg U et al. Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Research 2000; 100:49-58.
31. Tollefson GD, Andersen SW. Should we consider mood disturbances in schizophrenia as an important determinant of quality of life. Journal of Clinical Psychiatry 1999; 60:23-29.
32. Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophrenia Research 2001; 51:171-180.
33. Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin 1984; 10:388-398.
34. Bow-Thomas CC, Velligan DI, Miller AL, Olsen J. Predicting quality of life from symptomatology at exacerbation and stabilisation. Psychiatry Research 1999; 86:131-142.
35. Norman RMG, Malla AK, McLean T et al. The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the quality of life scale. Acta Psychiatrica Scandinavica 2000; 102:303-309.